These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19701560)

  • 21. Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications.
    Abate N
    J Diabetes Complications; 2000; 14(3):154-74. PubMed ID: 10989324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological treatment and therapeutic perspectives of metabolic syndrome.
    Lim S; Eckel RH
    Rev Endocr Metab Disord; 2014 Dec; 15(4):329-41. PubMed ID: 25342235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The metabolic syndrome].
    Suter PM
    Praxis (Bern 1994); 2003 Apr; 92(15):681-8. PubMed ID: 12731123
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic options for metabolic syndrome in obese patients].
    Carella AM; Conte M
    Clin Ter; 2007; 158(5):457-64. PubMed ID: 18062354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abdominal obesity and metabolic syndrome.
    Després JP; Lemieux I
    Nature; 2006 Dec; 444(7121):881-7. PubMed ID: 17167477
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic syndrome: is it a syndrome? Does it matter?
    Kahn R
    Circulation; 2007 Apr; 115(13):1806-10; discussion 1811. PubMed ID: 17404171
    [No Abstract]   [Full Text] [Related]  

  • 27. The metabolic syndrome and cardiovascular disease - an ongoing tsunami.
    Hanefeld M; Pistrosch F
    Pediatr Endocrinol Diabetes Metab; 2013; 20(1):5-11. PubMed ID: 25612864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of insulin resistance, dyslipidemia, and intra-abdominal adiposity on the development of cardiovascular disease and diabetes mellitus.
    Rader DJ
    Am J Med; 2007 Mar; 120(3 Suppl 1):S12-8. PubMed ID: 17320517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The metabolic syndrome and insulin resistance].
    Kotani K; Kaku K
    Nihon Rinsho; 2005 Aug; 63(8):1485-91. PubMed ID: 16101244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The metabolic syndrome: definitions, prevalence and management.
    Levesque J; Lamarche B
    J Nutrigenet Nutrigenomics; 2008; 1(3):100-8. PubMed ID: 19776619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of obesity on cardiovascular disease.
    Zalesin KC; Franklin BA; Miller WM; Peterson ED; McCullough PA
    Med Clin North Am; 2011 Sep; 95(5):919-37. PubMed ID: 21855700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome: a work in progress, but a useful construct.
    Beaser RS; Levy P
    Circulation; 2007 Apr; 115(13):1812-8; discussion 1818. PubMed ID: 17404172
    [No Abstract]   [Full Text] [Related]  

  • 33. The metabolic syndrome, type 2 diabetes, and cardiovascular disease: understanding the role of insulin resistance.
    Kendall DM; Harmel AP
    Am J Manag Care; 2002 Dec; 8(20 Suppl):S635-53; quiz S654-7. PubMed ID: 12510788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of metabolic syndrome.
    Wagh A; Stone NJ
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The relationship of obesity to the metabolic syndrome.
    Lebovitz HE
    Int J Clin Pract Suppl; 2003 Mar; (134):18-27. PubMed ID: 12793594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The metabolic syndrome in women.
    Schneider JG; Tompkins C; Blumenthal RS; Mora S
    Cardiol Rev; 2006; 14(6):286-91. PubMed ID: 17053375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic syndrome: definition and therapeutic implications.
    Prasad H; Ryan DA; Celzo MF; Stapleton D
    Postgrad Med; 2012 Jan; 124(1):21-30. PubMed ID: 22314111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Obesity and inflammation].
    Recasens M; Ricart W; Fernández-Real JM
    Rev Med Univ Navarra; 2004; 48(2):49-54. PubMed ID: 15382613
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metabolic Syndrome: Insulin Resistance and Prediabetes.
    Mayans L
    FP Essent; 2015 Aug; 435():11-6. PubMed ID: 26280340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview.
    Amihăesei IC; Chelaru L
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):896-900. PubMed ID: 25581945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.